Hurthle Cell Thyroid Cancer - 3 Studies Found

Recruiting : Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
: Refractory Hurthle Cell Thyroid Cancer
: 2014-05-19
:
  • Drug: sorafenib Given PO
Recruiting : IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
: Thyroid Cancer
: 2011-07-06
: Radiation: I131 1.1 GBq Radio-iodine Other Name: Sod
Completed : A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
: Thyroid Cancer
: 2005-07-12
: Drug: AMG 706